SCHEDULE: Viking Global Updates Stake in Rallybio
Schedule 13G Amendment
Viking Global Investors LP filed an amendment to its Schedule 13G, reporting a 9.99% beneficial ownership stake in Rallybio Corporation.
Summary
- Viking Global Investors LP and affiliated entities report a 9.99% beneficial ownership stake in Rallybio Corporation.
- The total beneficial ownership consists of 528,954 shares of common stock, including 524,347 shares directly owned and 4,607 shares issuable upon exercise of pre-funded warrants.
- The reporting entities include Viking Global Investors LP, various Viking Global Opportunities GP entities, O. Andreas Halvorsen, and Rose S. Shabet.
- David C. Ott has retired from his roles at the reporting entities and has been removed as a reporting person.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral regulatory disclosure reflecting a change in reporting personnel and an update to existing holdings.
Positives
- The filing confirms a significant institutional investment position of 9.99% in the issuer.
Negatives
- The filing notes the departure of a key executive, David C. Ott, from the reporting group.
Risks
- The warrants held by the reporting person are subject to a 9.99% ownership blocker, limiting immediate conversion and voting power.
- The reporting persons' ability to exercise warrants is subject to a 61-day notice period for any changes to the ownership blocker.
Future Outlook
The filing does not provide a forward-looking business outlook for the issuer, as it is a disclosure of beneficial ownership.
Industry Context
StockSavvy.ai notes that institutional filings like this are standard regulatory disclosures for investment firms and do not typically signal a change in the issuer's operational strategy, though they provide transparency into major shareholder movements.
Comparison to Industry Standards
- The filing adheres to standard SEC Schedule 13G requirements for passive institutional investors.
- The use of ownership blockers (9.99%) is a common practice for institutional investors to avoid triggering regulatory thresholds or 'control' status under the Securities Exchange Act.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Advisory Director of VGI and Executive Committee Member | David C. Ott | None | 03/31/2026 | Retirement |
Stakeholder Impact
- Shareholders may note the stability of the 9.99% position held by Viking Global.
Next Steps
- Continued monitoring of future 13G or 13D filings by the reporting group.
Key Dates
| Date | Description |
|---|---|
| 02/09/2021 | Date of authorization and designation letter for signatory. |
| 03/31/2026 | Date of event requiring filing and effective date of David C. Ott's retirement. |
| 05/13/2026 | Date of Issuer's Form 10-Q filing used for share count reference. |
| 05/15/2026 | Date of the Schedule 13G/A filing and Joint Filing Agreement. |
Keywords
Rallybio, Viking Global, Schedule 13G, Institutional Ownership, Biotech, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.